CHARCOT MARIE TOOTH DISEASE
Clinical trials for CHARCOT MARIE TOOTH DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHARCOT MARIE TOOTH DISEASE trials appear
Sign up with your email to follow new studies for CHARCOT MARIE TOOTH DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for rare nerve disease that weakens muscles
Symptom relief CompletedThis study tested whether a new drug called NMD670 could help adults with Charcot-Marie-Tooth disease (CMT) walk farther and feel better. For 21 days, 81 participants with CMT took either the drug or a placebo pill twice daily. Researchers measured changes in walking distance, fa…
Matched conditions: CHARCOT MARIE TOOTH DISEASE
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Symptom relief
Last updated Mar 24, 2026 08:43 UTC
-
Scientists create First-Ever test to track nerve disease in kids
Knowledge-focused CompletedThis study created and tested a new measurement tool specifically for children with Charcot Marie Tooth (CMT) disease, a genetic nerve disorder. Researchers worked with 500 children and young adults (age 21 and under) who have CMT, having them perform tasks like walking, climbing…
Matched conditions: CHARCOT MARIE TOOTH DISEASE
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC